86 related articles for article (PubMed ID: 23790044)
1. Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
Sen Gupta P; Grozinsky-Glasberg S; Drake WM; Akker SA; Perry L; Grossman AB; Druce MR
Clin Endocrinol (Oxf); 2014 Feb; 80(2):246-52. PubMed ID: 23790044
[TBL] [Abstract][Full Text] [Related]
2. A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs).
Tellez MR; Mamikunian G; O'Dorisio TM; Vinik AI; Woltering EA
Pancreas; 2013 Apr; 42(3):405-10. PubMed ID: 23160483
[TBL] [Abstract][Full Text] [Related]
3. 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients.
van Dijk SC; de Herder WW; Kwekkeboom DJ; Zillikens MC; Feelders RA; van Schaik RH; van Driel M; van Leeuwen JP
Bone; 2012 Jun; 50(6):1260-5. PubMed ID: 22425693
[TBL] [Abstract][Full Text] [Related]
4. [Determination of thresholds values for platelet serotonin and urinary 5-HIAA concentrations for the biological diagnosis of digestive neuroendocrine tumors].
Padelli M; Bruno C; Lemarchand J; Vourc'h P; Andres C; Blasco H; Benz-de Bretagne I
Ann Biol Clin (Paris); 2019 Apr; 77(2):161-168. PubMed ID: 30998196
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
Abeş M; Sarihan H; Madenci E
J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
[TBL] [Abstract][Full Text] [Related]
6. Plasma serotonin precursors and metabolite are correlated with bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
Feng Q; Song X; Liu L; Zhou X; Chen Z
J Orthop Surg (Hong Kong); 2024; 32(1):10225536231187181. PubMed ID: 38613416
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
8. Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours.
Zandee WT; Kamp K; van Adrichem RC; Feelders RA; de Herder WW
Eur J Endocrinol; 2016 Nov; 175(5):361-6. PubMed ID: 27491374
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Utility of 24-Hour Urinary 5-HIAA Doubling Time in Patients With Neuroendocrine Tumors.
Tirosh A; Nilubol N; Patel D; Kebebew E
Endocr Pract; 2018 Aug; 24(8):710-717. PubMed ID: 30084688
[TBL] [Abstract][Full Text] [Related]
10. Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate.
Earnshaw SA; Cawte SA; Worley A; Hosking DJ
Osteoporos Int; 1998; 8(1):53-60. PubMed ID: 9692078
[TBL] [Abstract][Full Text] [Related]
11. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
Laway BA; Goswami R; Singh N; Gupta N; Seith A
Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
Korse CM; Bonfrer JM; Aaronson NK; Hart AA; Taal BG
Neuroendocrinology; 2009; 89(3):296-301. PubMed ID: 18840995
[TBL] [Abstract][Full Text] [Related]
13. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis.
Patel R; Blake GM; Fogelman I
Calcif Tissue Int; 2007 Feb; 80(2):89-96. PubMed ID: 17308990
[TBL] [Abstract][Full Text] [Related]
14. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
Terzi T; Terzi M; Tander B; Cantürk F; Onar M
J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density and vertebral fractures in men.
Legrand E; Chappard D; Pascaretti C; Duquenne M; Rondeau C; Simon Y; Rohmer V; Basle MF; Audran M
Osteoporos Int; 1999; 10(4):265-70. PubMed ID: 10692973
[TBL] [Abstract][Full Text] [Related]
16. Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis.
Ribom EL; Ljunggren O; Mallmin H
J Clin Densitom; 2008; 11(3):404-11. PubMed ID: 18280191
[TBL] [Abstract][Full Text] [Related]
17. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
de Jong DJ; Corstens FH; Mannaerts L; van Rossum LG; Naber AH
Am J Gastroenterol; 2002 Aug; 97(8):2011-5. PubMed ID: 12190169
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register.
Haugeberg G; Uhlig T; Falch JA; Halse JI; Kvien TK
Arthritis Rheum; 2000 Mar; 43(3):522-30. PubMed ID: 10728744
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density and fracture threshold in South Indian elderly.
Usha G; Krishnaswamy B
J Assoc Physicians India; 2002 Feb; 50():247-9. PubMed ID: 12038657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]